For patients who experienced rapid and significant weight reduction while taking an SGLT-2 inhibitor or a GLP-1 agonist, ALT values normalized, suggesting a beneficial effect on liver health.
Mirum Pharmaceuticals Presents New Data at The Liver Meeting® streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
13.11.2023 - -As previously reported, the ALPINE 4 study met its primary endpoint, with aldafermin 3 mg demonstrating a statistically significant reduction in Enhanced Liver Fibrosis (ELF) score compared to placebo after 48 weeks of treatment- -ELF, an . Seite 1
Results showed decreased mortality rates among patients with severe alcohol-associated hepatitis treated with corticosteroids after the COVID-19 pandemic.